CBAK Energy (CBAT) Q4 2025 earnings review
Hyper-Growth Top Line Eclipsed by Margin Collapse During Transition
CBAK Energy achieved an explosive 131.8% YoY revenue growth in Q4, reaching $58.80M. However, this top-line surge completely decoupled from bottom-line realities. Net loss deepened to $7.38M as aggressive ramp-ups of new production lines (Model 40135 and 32140) and the phase-out of legacy cells triggered intense friction costs. Consolidated gross margin plummeted to 7.3% in Q4 from 13.1% a year ago. A 944% revenue spike in the Hitrans raw material segment served as a crucial counter-cyclical stabilizer, but core battery profitability remains heavily suppressed until facility transitions complete.
🐂 Bull Case
Light Electric Vehicle (LEV) battery sales skyrocketed 524% YoY to $12.92M in Q4, validating successful market penetration in India, Vietnam, and Africa.
The successful launch of 2.3 GWh (Model 40135) and 3.0 GWh (Model 32140) production lines sets the foundation for major volume expansion in 2026.
🐻 Bear Case
The transition phase is burning profitability. With Q4 gross margins at 7.3% and substantial operating losses (-$18.44M for FY25), executing the capacity ramp without severe cash burn is a major risk.
Residential Energy Supply revenues dropped 45% for the full year as customers paused orders to validate the new 40135 cell, showing vulnerability during product transitions.
⚖️ Verdict: ⚪
Neutral. The volume recovery and strategic shift to larger-format cells are necessary for long-term survival, but investors must endure a painful, capital-intensive transition period characterized by compressed margins and elevated execution risks.
Key Themes
Severe Gross Margin Contraction Amidst Expansion
A massive red flag emerged regarding profitability. Despite Q4 revenue more than doubling, gross profit margin decelerated sharply to 7.3% from 13.1% in the prior year. Management attributed this to friction costs, sub-optimal yields, and high fixed-cost absorption inherent to ramping up the new Model 40135 (Dalian) and Phase II Model 32140 (Nanjing) lines. This directly contradicts the bullish narrative of the explosive revenue growth.
Hitrans Segment Acts as Counter-Cyclical Stabilizer
The Hitrans battery raw materials segment experienced an unprecedented acceleration, with Q4 net revenues surging 944.1% YoY to $27.98M. Benefiting from a rebounding upward cycle in raw material pricing that materialized late in the year, it provided a vital cash flow buffer while the core battery business underwent its painful structural transition.
LEV Market Penetration Yields Hyper-Growth
Revenues from batteries used in Light Electric Vehicles (LEV) soared 524.2% YoY in Q4 to $12.92M, up from just $2.07M. This demonstrates accelerating traction in international markets—specifically India, Vietnam, and Africa—helping offset the temporary 10.6% Q4 decline in Residential Energy Supply.
Aggressive R&D for Next-Generation Cells
CBAK is not stopping at the 40135 model. Q4 R&D expenses jumped nearly 40% to $5.30M to fund materials and testing for commercializing next-generation large-format cylindrical cells: the 60115, 60135, and 60150 models. This underscores a long-term technology bet on larger, more cost-effective cylindrical formats to compete with mainstream prismatic cells.
Macro Headwind: Export Tax Rebate Phase-Out
Management flagged an impending regulatory shock: the PRC's export tax rebate for lithium-ion batteries drops to 6% in 2026 and zeroes out in 2027. This poses a significant risk to international margins. In response, CBAK established a Malaysian manufacturing subsidiary in April 2025 as a 'supply chain firewall', though capitalizing and ramping up an overseas plant introduces immense new execution risks.
Other KPIs
Despite a widening net loss of $10.95M, CBAK reported positive operating cash flow of $48.55M. However, this was primarily driven by working capital engineering—specifically a massive $63.66M increase in trade and bills payable. While it preserves short-term liquidity ($75.68M in cash), this stretches supplier payment terms significantly.
Accelerating significantly faster than historical norms, Cost of Revenues increased 147.1% YoY, outpacing the 131.8% revenue growth. This metric visually explains the gross margin collapse, driven directly by inefficiencies in the trial runs and initial commissioning of the new Dalian and Nanjing lines.
More than doubled from $85.49M at the end of 2024. Construction in progress also shifted downward to $32.05M as new capacity (5.3 GWh combined) officially came online. Capital expenditures for the year were heavy at $44.65M, illustrating the capital intensity of the current product pivot.
Guidance
Accelerating. Management confidently projected that consolidated sales will hit a record high in 2026. This outlook is anchored by 'insatiable demand' for the newly launched Model 32140 and 40135 cells, which currently vastly exceed supply.
Reversing. The company expects gross margins to recover sequentially throughout 2026 as production yields optimize and economies of scale are realized on the newly commissioned Nanjing and Dalian lines. The recovery from the 7.3% Q4 trough will be the primary metric to watch.
Stable. While the lines are currently online, management noted that the intensive capacity ramp-up for Phase II will fully complete by early 2027, leading to a 'significant operational turnaround' and sustained resurgence in bottom-line profitability.
Key Questions
Margin Normalization Timeline
Gross margins collapsed to 7.3% in Q4 due to transition friction. What is the specific timeline and target utilization rate required for margins to return to historical 20%+ levels?
Hitrans Sustainability
Hitrans revenue grew an extraordinary 944% in Q4. How much of this was purely driven by raw material spot price increases versus actual volume expansion, and how sustainable is this run-rate into 2026?
Malaysia Factory Capitalization
With the Malaysian subsidiary established to counter the PRC tax rebate phase-out, what is the estimated CapEx required to bring this facility to mass production, and how will it be funded given current operating losses?
Model 40135 Validation Status
Residential energy supply sales dropped 45% as customers paused to validate the new 40135 cells. What percentage of legacy 26650 customers have officially signed off on the new format, and when will volume shipments begin?